Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-07
2011-12-06
Kosar, Andrew D (Department: 1622)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S333500
Reexamination Certificate
active
08071785
ABSTRACT:
Radioactively labeled derivatives of (R)-3-(1-phenylethyl)-3H-imidazole-4-carboxylic acid esters and one-step methods for preparing these compounds are provided. The radioactively labelled compounds, and pharmaceutical acceptable salts and solvates are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography (PET) for the diagnosis of adrenal cortical masses such as incidentaloma, adenoma, primary and metastatic cortical carcinoma. Associated kits and method for PET studies are also provided.
REFERENCES:
patent: 7189859 (2007-03-01), Zolle et al.
patent: 7358369 (2008-04-01), Zolle et al.
patent: 2005/0033060 (2005-02-01), Zolle et al.
Wadsak, et.al. “Synthesis of [18F]FETO, a novel potential 11 -hydroxylase inhibitor” Journal of Labelled Compounds and Radiopharmaceuticals, J. Wiley, Chichester, GB, vol. 45, No. 4, Nov. 30, 2004, pp. 379-388.
Wadsak, et.al. “[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers” European Journal of Nuclear Medicine and Molecular Imaging, Springer-Verlag, BE, vol. 33, No. 6 Mar. 28, 2006, pp. 669-672.
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Wadsak et al, (Eur. J. Nuc. Med (2006)).
Wadsak et al, (J. Label Compd Radiopharm. (2003)).
Mitterhauser et al, (Eur J. Nucl. Med. (2003), 30 (10); 1398-1401).
Ansel et al. “Pharmaceutical Dosage Forms and Drug Delivery Systems”, 5th ed. (1990), Lea & Febiger, Philadelphia; p. 92-99.
Lepareur et al. (J. Label Compd. Radiopharm. (2004); 47:857-867).
Patani et al. (Chem. Rev., 1996, 96(8), 3147-3176).
Wadsak, et.al. “Synthesis of [18F]FETO, a novel potential 11-hydroxylase inhibitor” Journal of Labelled Compounds and Radiopharmaceuticals, J. Wiley, Chichester, GB, vol. 45, No. 4, Nov. 30, 2004, pp. 379-388.
Wadsak, et.al. “[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers” European Journal of Nuclear Medicine and Molecular Imaging, Springer-Verlag, BE, vol. 33, No. 6 Mar. 28, 2006, pp. 669-672.
PCT/IB2007/001528 Int'l Search Report/Written Opinion dated Dec. 2007.
Blom Elisabeth
Erlandsson Maria
Karimi Farhad
Langstrom Bengt
GE Healthcare Limited
Kosar Andrew D
Rodriguez-Garcia Valerie
LandOfFree
Synthesis and evaluation of 18 F-labelled-alkyl-1-[(1 R... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis and evaluation of 18 F-labelled-alkyl-1-[(1 R..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis and evaluation of 18 F-labelled-alkyl-1-[(1 R... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4272347